Insertion/deletion polymorphism of angiotensin converting enzyme gene in Kawasaki disease

Journal of Korean Medical Science

Volumn 21, Issue 2, 2006, Pages 208-211

  Yoon, Hee Shim ^a   Hae, Soon Kim ^a,b   Sohn, Sejung ^a   Young, Mi Hong ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Mokdong Hospital   (South Korea)

Author keywords

Angiotensin Converting Enzyme; Kawasaki Disease; Mucocutaneous Lymph Node Syndrome; Peptidyl Dipeptidase A; Polymorphism, Genetic

Indexed keywords

EID: 33646760663     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.2.208     Document Type: Article

References (27)

1. Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr 2004; 16: 508-14.
2. Yanagawa H, Yashiro M, Nakamura Y. 14th nationwide survey on Kawasaki disease. J Pediatr Practice 1998; 61: 406-20.
3. Shulman ST, Rowley AH. Does Kawasaki disease have a retroviral aetiology? Lancet 1986; 2: 545-6.
4. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human Coronavirus and Kawasaki disease. J Infect Dis 2005; 191: 499-502.
5. Chou CT, Chang JS, Ooi SE, Huo AP, Chang SJ, Chang HN, Tsai CY. Serum anti-Yersinia antibody in Chinese patients with Kawasaki disease. Arch Med Res 2005; 36: 14-8.
6. Hagiwara K, Komura H, Kishi P, Kaji T, Yoshida T. Isolation of human herpesvirus-6 from an infant with Kawasaki disease. Eur J Pediatr 1992; 151: 867-8.
7. Baba K, Takeda N, Tanaka M. Cases of Yersinia pseudotuberculosis infection having diagnostic criteria of Kawasaki disease. Contrib Microbiol Immunol 1991; 12: 292-6.
8. Lee DH, Huang HP. Kawasaki disease associated with chickenpox: report of two sibling cases. Acta Paediatr Taiwan 2004; 45: 94-6.
9. Kang JH, Lee JS. The role of EBV in the development of Kawasaki disease. 5th West-Pacific allergy symposium 1997; 241-4.
10. Rocholl C, Gerber K, Daly J, Pavia AT, Byington CL. Adenoviral infections in children: the impact of rapid diagnosis. Pediatrics 2004; 113: e51-6.
11. Kim DS. Immunologic aspect in Kawasaki disease. J Korean Pediatr Cardiol Soc 2003; 7: 306-10.
12. Rowley AH, Shulman ST. Kawasaki syndrome. Pediatrc Clin N Am 1999; 46: 313-29.
13. Wu SF, Chang JS, Peng CT, Shi YR, Tsai FJ. Polymorphism of angiotenisn-1 converting enzyme gene and Kawasaki disease. Pediatr Cardiol 2004; 25: 529-33.
14. Hubert C, Houot AM, Corvol P, Soubrier F. Structure of angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991; 266: 15377-83.
15. Manning MW, Cassis LA, Daugherty A. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2003; 23: 483-8.
16. Lamblin N, Hermant X, Lablanche JM, Helbecque N, Amouyel P, Bauters C. Angiotensin converting enzyme and angiotensin II type I receptor polymorphisms in patients with coronary aneurysms. Thromb J 2003; 1: 5-11.
17. Prasad A, Narayanan S, Waclawiw MA, Epstein N, Quyyumi AA. The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity. J Am Coll Cardiol 2000; 36: 1579-86.
18. Scheer WD, Boudreau DA, Hixson JE, McGill HC, Newman WP 3rd, Tracy RE, Zieske AW, Stong JP. ACE insert/delete polymorphism and atherosclerosis. Atherosclerosis 2005; 178: 241-7.
19. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
20. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
21. Frossard PM, Lestringant GG, Obineche EN, Hill SH. The angiotensin-converting enzyme (ACE) gene insertion/deletion dimorphism tracks with higher serum ACE activities in both younger and older subjects. Ann Saudi Med 1998; 18: 289-392.
22. Danser AH, Schunkert H. Renin-angiotensin system gene polymorphism: potential mechanisms for their association with cardiovascular diseases. Eur J Pharmacol 2000; 410: 303-16.
23. Caldwell PR, Segal BC, Hsu KC, Das M, Softer RL. Angiotensin converting enzyme: vascular endothelial localization. Science 1976; 191: 1050-1.
24. Falcini F, Generini S, Pigone A, Leoncini G, Cimaz R, Partsch G, Matucci-Cerinic M. Are angiotensin converting enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease. Endothelium 1999; 6: 209-15.
25. Fukazawa R, Sonobe T, Hamamoto K, Hamaoka K, Sakata K, Asano T, Imai T, Kamisago M, Ohkubo T, Uchikoba Y, Ikegami E, Watanabe M, Ogawa S. Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res 2004; 56: 597-601.
26. Slowik A, Borratynsky A, Pera J, Betlej M, Dziedzic T, Krzyszkowski T, Czepko R, Figlewicz DA, Szczudlik A. II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm. Stroke 2004; 35: 1594-97.
27. Takeuchi K, Yamamoto K, Kataoka S, Kakihara T, Tanaki A, Sato S, Uchiyama M. High incidence of angiotensin 1 converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm. Eur J Pediatr 1997; 156: 266-8.